See also this year's filing and all EDGAR filings for this company.
PDF Report 0001535955_2026_Lipocine_Inc.pdf
Logs
Graph
Absolute values for 0001535955, Lipocine Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,877,566 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 104,293 |
| 3 | remainder_Assets | 23,753 |
| 4 | LiabilitiesCurrent | 2,528,196 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,699,138 |
| 9 | ResearchAndDevelopmentExpense | 8,550,906 |
| 10 | remainder_Expenses | 365 |
| 11 | remainder_Revenues | 5,311,872 |
| 12 | remainder_NetIncome | 760,080 |
| 13 | remainder_ComprehensiveNetIncome | -2,439 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 17,005,612 |
| 1 | Liabilities | 2,528,196 |
| 2 | Expenses | 12,250,409 |
| 3 | Revenues | 5,311,872 |
| 4 | StockholdersEquity | 14,477,416 |
| 5 | NetIncome | -6,178,457 |
| 6 | ComprehensiveNetIncome | -6,179,676 |
| 7 | BaseVar | 18,929,304 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.60 |
| 9 | EconomicCapitalRatio | 3.42 |
Edgar->Model Mapping
Feature Distribution
Change over Time
